Molson Coors, the US brewer, has announced it has secured exclusive rights to produce, market, sell, and distribute the Fever-Tree brand of tonics, ginger beers and mixers in the US as of February 2025.
As part of the deal, Molson Coors will also acquire an 8.5% stake in Fever-Tree for $88.3 million, making it the company’s second-largest shareholder.
Commenting on the deal, Molson Coors chief executive officer Gavin Hattersley said: “The U.S. is our biggest global market by revenue, and the same is true for Fever-Tree, so we believe this partnership provides ample opportunity for our teams to build on the strong success Fever-Tree has achieved to date. Our customers have been asking for a brand just like Fever-Tree from us”.
Molson Coors chief commercial officer Michelle St. Jacques added: “Fever-Tree sits at the intersection of beer and non-alc and is often available in stores where beer is sold, so it perfectly complements our Beyond Beer and premiumization strategies, playing in both alcohol occasions and non-alc occasions”.
Fever-Tree CEO Tim Warrilow said: “With a distribution network of their scale and muscle, proven track record, supply chain expertise and clearly stated strategic desire to drive the future of their business beyond beer, we believe Molson Coors is the ideal partner to take the Fever-Tree brand to the next level across the US”.
Source: Molson Coors